References
- Yuille M. R., Houlston R. S., Catovsky D. Anticipation in familial chronic lymphocytic leukaemia. Leukemia 1998; 12: 1696–1608
- Adami J., Gridley G., Nyren O., Dosemeci M., Linet M., Glimelius B., Ekbom A., Zahm S H. Sunlight and non-Hodgkin lymphoma: a population-based cohort study in Sweden. International Journal of Cancer 1999; 80: 641–645
- Pogribny I. P., Muskhelishvili L., Miller B. J., James S. J. Presence and consequence of uracil in preneoplastic DNA from folate/methyl-deficient rats. Carcinogenesis 1997; 18: 2071–2076
- Blount B. C., Mack M. M., Wehr C. M., MacGregor J. T., Hiatt R. A., Wang G., Wickramasinghe S. N., Everson R. B., Ames B. N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proceedings of the National Academy of Sciences of the USA 1997; 94: 3290–3295
- Tseng M., Murray S. C., Kupper L. L., Sandler R. S. Micronutrients and the risk of colorectal adenomas. American Journal of Epidemiology 1996; 144: 1005–1014
- Kato I., Dnistrian A. M., Schwartz M., Toniolo P., Koenig K., Shore R. E., Akhmedkhanov A., Zeleniuch-Jacquotte A., Riboli E. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. British Journal of Cancer 1999; 79: 1917–1922
- Zhang S., Hunter D. J., Hankinson S. E., Giovannucci E. L., Rosner B. A., Colditz G. A., Speizer F. E., Willett W. C. A prospective study of folate intake and the risk of breast cancer. Journal of the American Medical Association 1999; 28: 1632–1637
- Skibola C. F., Smith M. T., Kane E., Roman E., Rollinson S., Cartwright R. A., Morgan G. Polymorphism in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proceedings of the National Academy of Sciences of the USA 1999; 96: 12810–12815
- Frosst P., Bloom H. J., Milos R., Goyette P., Sheppard C. A., Matthews R. G., Boers G. J., den Heijer M., Kluijtmans L. A., van den Heuvel L. P., Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetic 1995; 10: 111–113
- Gemmati D., Previati M., Serino M. L., Moratelli S., Guerra S., Capitani S., Forini E., Ballerini G., Scapoli G. L. Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects. Arteriosclerosis Thrombosis and Vascular Biology 1999; 19: 1761–1767
- Brattström L., Wilcken D. E.L., Öhrvik J., Brudin L. Common methylenetetrahydrofolate reductase gene mutations leads to hyperhomocysteinemia but not to vascular disease. The result of a meta-analysis. Circulation 1998; 98: 2520–2526
- Kluijtmans L. A.J., den Heijver M., Reitsma P. H., Heil S. G., Blom H. J., Rosendaal E. R. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thrombosis and Haemostasis 1998; 79: 254–8
- Epitable Software. Centers for Disease Control, Atlanta, GeorgiaUS, 6 epidemiological package vs. 2.0 Coulombier DM. Division of Surveillance and Epidemiology
- The Twobytwo Analyzer (Version 1.0). 1992, Roben M. Centor and Jerry Keightley. Blue Ridge Express BBS. Richmond. Virginia. US
- Ma J., Stampfer M J., Giovannucci E., Artigas C., Hunter D J., Fuchs C., Willett W C., Selhub J., Hennekens C H., Rozen R. Methylenetetrahydrofolate reductase polymorphism. dietary interactions. and risk of colorectal cancer. Cancer Research 1997; 57: 1098–1102
- Gudnason V., Stansbie D., Scott J., Bowron A., Nicaud V., Humphries S. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. Atherosclerosis 1998; 136: 347–354